Scarica l'app Stockscreener
15.55
13.37%
-2.40
Dopo l'orario di chiusura:
15.70
0.15
+0.96%
Precedente Chiudi:
$17.95
Aprire:
$17.65
Volume 24 ore:
725.62K
Relative Volume:
1.72
Capitalizzazione di mercato:
$964.56M
Reddito:
-
Utile/perdita netta:
$-41.43M
Rapporto P/E:
-19.68
EPS:
-0.79
Flusso di cassa netto:
$-39.97M
1 W Prestazione:
+22.44%
1M Prestazione:
+6.29%
6M Prestazione:
+7.46%
1 anno Prestazione:
+73.16%
Intervallo 1D:
$15.52
$17.65
Intervallo di 1 settimana:
$12.80
$19.00
Portata 52W:
$7.98
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Confronta GHRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
15.55 | 1.11B | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
How strong is GH Research PLC stock balance sheet2025 Valuation Update & Weekly High Conviction Ideas - ulpravda.ru
What dividend safety score for GH Research PLC stock2025 Top Gainers & Weekly High Conviction Trade Ideas - ulpravda.ru
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting - TipRanks
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 Trials - Yahoo Finance UK
Stock market today: S&P 500, Nasdaq futures rise, WTI fluctuates following US strike on Venezuela—GH Research, Vertiv Holdings, Nukkleus in focus - MSN
Why Is GHRS Stock Rising Today? - Asianet Newsable
What drives GH Research PLC stock priceDividend Reinvestment Plans & Outstanding Capital Tips - earlytimes.in
Why is GHRS stock rising today? - MSN
Will GH Research PLC (1KA) stock gain from green policies2026 world cup usa national team round of 32 playmakers pressing system odds analysis tactical review - ulpravda.ru
GH Research (NASDAQ:GHRS) Stock Price Down 9.2%Should You Sell? - MarketBeat
GH Research stock price target raised to $29 from $19 at Needham - Investing.com Nigeria
GH Research stock rises as FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock jumps as Canaccord raises price target on FDA hold lift - Investing.com
GHRS Stock Sees Significant Price Target Increase by Needham | G - GuruFocus
GH Research (GHRS) Is Up 24.2% After FDA Lifts Hold On GH001 U.S. Trial Enrollment - simplywall.st
Hold lifted, as GH Research preps for pivotal GH-001 depression trial - BioWorld MedTech
GH Research stock rating reiterated as Buy by TD Cowen - Investing.com Nigeria
GH Research says FDA lifts clinical hold on GH001 - TipRanks
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT By Investing.com - Investing.com South Africa
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - Benzinga
GH Research (NASDAQ:GHRS) Shares Gap UpTime to Buy? - MarketBeat
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT - Investing.com Australia
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted By Investing.com - Investing.com South Africa
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
US Stocks Higher; Dow Jumps 250 Points - Benzinga
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted - Investing.com Nigeria
Why Is GH Research Stock Soaring Monday?GH Research (NASDAQ:GHRS) - Benzinga
Why GH Research Is Rising In Pre-market? - Nasdaq
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Gh Research shares jump 44% premarket after US FDA lifts clinical hold on depression drug trials - MarketScreener
GHRS: Needham Reiterates Buy Rating and $19 Price Target | GHRS Stock News - GuruFocus
GH Research surges as FDA lifts clinical hold on depression therapy - Seeking Alpha
GH Research (NASDAQ:GHRS) Receives Buy Rating from Needham & Company LLC - MarketBeat
GH Research Says FDA Lifted Clinical Hold on Investigational New Drug Application for GH001; Shares Rise Pre-Bell - marketscreener.com
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression - TipRanks
GH Research stock soars after FDA lifts clinical hold on GH001 By Investing.com - Investing.com South Africa
GH Research stock soars after FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock grabs retail spotlight ahead of FDA update on depression treatment - MSN
GH Research : Corporate Presentation - marketscreener.com
NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday - Benzinga
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 - The Manila Times
FDA clears next-step testing of fast-acting drug for tough-to-treat depression - Stock Titan
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
GH Research Holdings Inc (NASDAQ:GHRS) Nasdaq Composite ETF Biotech Scope - Kalkine Media
What analysts say about GH Research PLC 1KA stockEnergy Sector Updates & Free Explosive Return Secrets - earlytimes.in
GH Research: GH001 Shows Robust Data Ahead Of FDA IND Decision (NASDAQ:GHRS) - Seeking Alpha
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment - Stocktwits
GH Research stock rises on upcoming trial update (GHRS:NASDAQ) - Seeking Alpha
GH Research to provide update on FDA application for depression drug - Investing.com Nigeria
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):